Recent research has found OLFM4 to be highly expressed in proliferative-phase endometrium, and OLFM4 expression is associated with the presence of epidermal growth factor receptor-1 and oestrogen receptor-α (ERα) in endometriosis and endometrial cancer [20]. Here, ESR1 is linked to endometrial cancer.